Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C. - Wikidata - wikimedia - TriplyDB

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.

http://www.wikidata.org/entity/Q33410537

about

Effects of Helicobacter pylori Eradication on the Platelet Count in Hepatitis C Virus-Infected Patients Effect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients.

P2860

Q33436669-3A194485-8AC1-4C66-8A7B-00638EE16398 Q34467312-33834772-D4C6-4D4D-BD5F-E6210D2CE9E9

P2860

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.

http://www.wikidata.org/entity/Q33410537

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Thrombocytopenia in pegylated ...... erapy for chronic hepatitis C.

@ast

Thrombocytopenia in pegylated ...... erapy for chronic hepatitis C.

@en

type

label

Thrombocytopenia in pegylated ...... erapy for chronic hepatitis C.

@ast

Thrombocytopenia in pegylated ...... erapy for chronic hepatitis C.

@en

prefLabel

Thrombocytopenia in pegylated ...... erapy for chronic hepatitis C.

@ast

Thrombocytopenia in pegylated ...... erapy for chronic hepatitis C.

@en

P1433

Q33410537-CFB6E094-B042-4280-8118-C3ED96014D7D

P1476

Q33410537-39EEC158-5B5D-467E-A520-EF05C9063075

P2093

Q33410537-23FA7687-EE37-470A-BB22-A095D599D730

Q33410537-2A241DD8-17B3-4354-9520-46EF43E0464A

Q33410537-34EF00FF-75BE-4B34-8BB8-E0646550629F

Q33410537-35CAA2F5-7D98-46FC-B745-56C2B9FD5FF9

Q33410537-6730FE7E-2717-495F-9B94-F0E9B199FE4C

Q33410537-88143A12-D370-4577-A719-562F9BA5027D

Q33410537-B93E5C8B-C189-495D-B5E5-3385E51B6375

Q33410537-C47C6855-FD1F-405C-B858-1CD276F6F9CA

Q33410537-C9B272AE-FDDC-4BB8-A286-76C0431D615D

Q33410537-E0F78BC7-89F7-4865-A193-4B531404512C

P2860

Q33410537-025177B8-281D-4DA4-B076-4BC9F180EAB2

Q33410537-187523EB-F8DC-47B9-8E0B-73C684A0614B

Q33410537-1F18CBC3-A8F0-4074-BC01-67BAFEA073C2

Q33410537-1FAC90E8-3183-4134-809C-E101860ADD1C

Q33410537-28C6E03D-4E0B-4E5F-877B-8FE8931856AB

Q33410537-2F591DB1-B7A5-4416-8F22-3C020FAD23F4

Q33410537-412C6571-2F22-4CC1-8113-7A134461C3E7

Q33410537-4C7323DC-9A7A-4DF1-B298-5B8EB3B13739

Q33410537-53A24B1E-DDEB-4C71-AC4F-BE838AC1A251

Q33410537-5486A838-EBC2-47A1-8688-1B18278F8E89

P304

Q33410537-734546E2-E264-4C7F-B413-9C5C08DFCFA7

P31

Q33410537-69B40AAB-64BF-471C-BAAC-2311DE0C13C0

P356

Q33410537-7E645F89-2811-4C19-BD2B-F3F5528A3420

P433

Q33410537-B0BA28A9-62F4-4492-B4DB-7A05398FE4B1

P478

Q33410537-A6CE8834-7FF6-4E48-B320-12DBC8B0556D

P577

Q33410537-CCBE2BFB-C7FB-4891-A3AF-EE563D6BC4C5

P5875

Q33410537-1EB2AA7E-2843-491D-BA45-6F0157B3BFC8

P698

Q33410537-3B5F670C-7C4C-477E-8B54-ABF5A50D6AF8

P921

Q33410537-395E4ED6-CE35-4EE8-A4ED-46745FE91DDA

P932

Q33410537-CDA20BF7-DD07-48B9-B577-6C0A7110E092

P356

S00535-013-0884-0

P1433

Journal of Gastroenterology

P1476

Thrombocytopenia in pegylated ...... erapy for chronic hepatitis C.

@en

P2093

Hirayuki Enomoto

http://www.w3.org/2001/XMLSchema#string

Hiroko Iijima

http://www.w3.org/2001/XMLSchema#string

Hironori Tanaka

http://www.w3.org/2001/XMLSchema#string

Hiroyasu Imanishi

http://www.w3.org/2001/XMLSchema#string

Kazunari Iwata

http://www.w3.org/2001/XMLSchema#string

Masaki Saito

http://www.w3.org/2001/XMLSchema#string

Naoto Ikeda

http://www.w3.org/2001/XMLSchema#string

Nobuhiro Aizawa

http://www.w3.org/2001/XMLSchema#string

Shuhei Nishiguchi

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Takashima

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization.

Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.

Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia.

Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia.

Splenectomy and antiviral treatment for thrombocytopenic patients with chronic hepatitis C virus infection.

P304

1253-1263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00535-013-0884-0

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257071822

http://www.w3.org/2001/XMLSchema#string

P698

24065124

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

P932

4124258

http://www.w3.org/2001/XMLSchema#string